Boston Scientific Announces Results For Third Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr
October 24, 2018 12:52 PM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as revenue missed consensus due to currency while its EPS beat consensus. Meanwhile, management lowered its revenue guidance due to currency and narrowed its EPS guidance.
Matson... More
Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
October 24, 2018 6:33 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Boston Scientific sees FY2018 EPS of $1.38-$1.40, versus the consensus of $1.40.... More
